A detailed history of Advisor Group Holdings, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 545,967 shares of ABBV stock, worth $98.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
545,967
Previous 585,102 6.69%
Holding current value
$98.3 Million
Previous $100 Million 7.43%
% of portfolio
0.26%
Previous 0.25%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $6.41 Million - $7.8 Million
-39,135 Reduced 6.69%
545,967 $108 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $8.13 Million - $9.49 Million
-52,513 Reduced 8.24%
585,102 $100 Million
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $45.7 Million - $52.1 Million
-286,077 Reduced 30.97%
637,615 $116 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $39.2 Million - $44.1 Million
-284,843 Reduced 23.57%
923,692 $143 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $31.3 Million - $36.2 Million
234,179 Added 24.03%
1,208,535 $180 Million
Q2 2023

Aug 21, 2023

SELL
$132.51 - $164.9 $71.3 Million - $88.7 Million
-537,861 Reduced 35.57%
974,356 $131 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $63.6 Million - $79.2 Million
480,034 Added 46.51%
1,512,217 $204 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $63,628 - $73,277
-440 Reduced 0.04%
1,032,183 $164 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $6.93 Million - $8.32 Million
50,137 Added 5.1%
1,032,623 $167 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $5.84 Million - $6.7 Million
43,508 Added 4.63%
982,486 $132 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $6.4 Million - $8.14 Million
-46,507 Reduced 4.72%
938,978 $144 Million
Q1 2022

May 04, 2022

SELL
$131.98 - $163.75 $182,792 - $226,793
-1,385 Reduced 0.14%
985,485 $151 Million
Q3 2021

Nov 05, 2021

BUY
$106.4 - $120.78 $5.28 Million - $6 Million
49,650 Added 5.3%
986,870 $107 Million
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $3.91 Million - $4.35 Million
37,128 Added 4.12%
937,220 $106 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $6.97 Million - $7.68 Million
68,155 Added 8.19%
900,092 $97.5 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $3.61 Million - $4.88 Million
44,911 Added 5.71%
831,937 $89.2 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $825,681 - $969,077
-9,611 Reduced 1.21%
787,026 $69.2 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $119 Million - $160 Million
-1,628,578 Reduced 67.15%
796,637 $78.2 Million
Q1 2020

May 18, 2020

BUY
$64.5 - $97.79 $156 Million - $237 Million
2,425,215 New
2,425,215 $57.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.